Jonathan M. Holmes, M.D.
(Fellowship 1992), was appointed Professor and Chair of Ophthalmology and Vision Science at the University of Arizona College of Medicine-Tucson on July 31, 2020. Prior to accepting this position, Dr Holmes was the Joseph E. and Rose Marie Green Professor of Visual Sciences and Professor of Ophthalmology at the Mayo Clinic in Rochester, Minnesota.
Dr. Holmes is currently the co-chair of the Pediatric Eye
Disease Investigator Group, a NIH-funded network conducting clinical trials in pediatric eye care and strabismus. He has additional NIH funding to develop patient-reported outcome measures across the spectrum of childhood eye conditions. Dr. Holmes is also an internationally recognized strabismus surgeon focusing on complex ocular misalignment and double vision in children and adults.
“My fellowship with Dr. Monte Del Monte and Dr. Steven
Archer at Kellogg gave me the toolbox I needed to carry into the rest of my career. More than anything, they taught me how to think, how to approach novel problems in strabismus and pediatric ophthalmology. I am forever indebted to them.”
Integrating Data Sciences and Imaging to Create Personalized Care for Corneal Ulcers Innovative research by Mia Woodward, M.D., M.S., in the
Brenda L. Bohnsack, M.D., Ph.D.
field of corneal ulcers, also known as microbial keratitis (MK),
(Residency, 2007-2010), was recently
has earned her a National Eye Institute R01 grant. The study —
appointed new Division Head of
a collaborative effort with Aravind Eye Care and other investi-
Ophthalmology at Ann & Robert H.
gators from U-M and Duke University — is focused on creating
Lurie Children’s Hospital of Chicago
images and data tools to understand the severity of corneal
and associate professor of ophthal-
ulcers, a leading cause of blindness worldwide, and to help
mology at Northwestern University
physicians with treatment and risk stratification decisions. There
Feinberg School of Medicine.
are currently no uniform strategies to measure a patient’s MK
condition or risk factors. This study will provide novel insights
Dr. Bohnsack was previously a
faculty member at Kellogg after having
into the features associated with clinical outcomes for MK,
been a resident at Michigan. She served as the Pediatric
which will allow clinicians to have practical, low-cost strategies
Ophthalmology and Adult Strabismus Fellowship Director
and technologies (imaging and electronic health records) to
and was the Helmut F. Stern Career Development Professor.
quantify MK features and to risk-score patients.
Her clinical interests include diagnosis and management
Applying readily available low-cost technologies to new
of congenital eye diseases and childhood glaucoma. A
care models will enable eye problems to be addressed before
renowned vision researcher, Dr. Bohnsack’s work involves
they cause damage to the eye and permanent vision loss in com-
investigating molecular mechanisms underlying ocular devel-
munities across the US and around the world. By personalizing
opment in the embryo to better understand congenital eye
treatments earlier and more accurately, Dr. Woodward's study
diseases and pave the way for new treatment strategies.
seeks to improve patient outcomes, especially in vulnerable populations.
NIH R01 GRANTS 25
